18 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Autism Speaks Request for Applications: Treatment Research Grants: Full- and Pilot-Level 2012 Cycle
Letter of Intent due: February 23, 2012, 8:00 PM Eastern Autism Speaks invites both Full- and Pilot-Level Treatment research grant applications to conduct innovative clinical studies of novel interventions for individuals with Autism Spectrum Disorders (ASD) throughout the lifespan. These may include medical approaches including complementary and alternative forms of health care and pharmacological treatments, as well as behavioral and/or psychosocial interventions, and evaluation of the efficacy, safety or therapeutic benefits of all types of interventions. Also appropriate are animal model studies that test the effects of novel compounds for reducing autism symptoms.
For all RFAs, Autism Speaks is focusing on a set of targeted research priorities for 2012. All treatment study projects will be required to demonstrate direct relevance to at least one of these targeted research priorities:
1. Understand environmental risk factors and their interaction with genetic susceptibility to enable prevention and improve diagnosis and treatment
2. Discover biomarkers that can improve risk assessment and subtype stratification that will allow for an individualized approach to treatment
3. Improve quality of life through more effective medicines, behavioral interventions, and technologies
4. Enhance diagnosis and treatment of underserved and under-studied populations, specifically,
• Nonverbal persons with ASD • Ethnically-diverse and/or low resource communities • Adults • Those with medical co-morbidities
5. Disseminate and implement evidence-based clinical practices to the broader community worldwide IMPORTANT: The relevance of the proposed research to ASD and Autism Speaks’ research priority areas must be explicitly described in the Letter of Intent (LOI) and full application.
Awards Autism Speaks will make a limited number of treatment research grants determined by the available financial resources. Full-level research grant 1-3 years $150,000/year maximum
Pilot-level research grant 1-2 years $60,000/year maximum
Autism Speaks utilizes a web-based application system for their grant submissions. All applications must be submitted through this system. It is imperative to indicate whether the submission is for the Full- or Pilot-Level Treatment research option.
Research Inquiries research@autismspeaks.org
Epilepsy Therapy Project/Epilepsy Foundation New Therapy - Commercialization Grants Program
Letter of Intent due: March 1, 2012, 11:59 PM ET
If LOI is accepted, APPLICATION is due: April 12, 2012, 11:59 PM ET
The New Therapy - Commercialization Grants Program is a unique partnership between two leading epilepsy non-profit organizations, the Epilepsy Therapy Project and the Epilepsy Foundation. The mission of the New Therapy - Commercialization Grants Program is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. Funding is provided to academic and commercial groups worldwide. The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Preference will be given to proposals that already have a commercial partner engaged to assist with development, and to proposals that have committed or matched funding from a sponsoring institution, commercial partner or other third party source.
Applicants must demonstrate background work beyond the basic science discovery stage.
Areas of interest include:
Novel approaches to treatment. Platform technology to advance screening techniques that can be utilized by multiple laboratories, including utility of techniques for early proof-of-concept trials. Adaptation of treatment in development for another therapeutic area to assess utility for epilepsy (while maintaining patent protection).
All proposals will be evaluated by our Business and Scientific Advisory Boards, as described below:
Proposals are rated on the likelihood of success by the Business Advisory Board as:
Intellectual Property Strategy & Status; Freedom To Operate Can this Get to Patients: Investment Potential & Likelihood of Ongoing Funding Support Probability of Success / Time Factor Fit with Program Mission / Patient Impact Overall Impression
Proposals are rated on the likelihood of success by the Scientific Advisory Board as:
Quality of Science Probability of Successful completion of milestones / outlined program Timeframe of Success Fit with Program Mission / Impact on Patients Overall Impression
These grants are awarded only to programs that have progressed beyond the basic science discovery stage. Investigators are strongly advised to have their compounds screened, as appropriate, by the NINDS ASP Program, http://www.ninds.nih.gov/research/asp/index.htm. Investigators are expected to have an established record of achievement in the area. Full intellectual property (IP) rights (composition of matter) are preferred over method of use IP. Clinical programs must have a reasonable protocol and sample size to assure that the results will be meaningful; studies of patients should describe the type of seizure/epilepsy that will be investigated. Device programs should present novel concepts for treatment.
Confidential information should NOT be sent to ETP or provided in any grant application without advance discussion with ETP and only with appropriate confidentiality agreements.
Scientific questions about appropriateness of an application should be directed to Roger J. Porter, MD, roger@epilepsytherapyproject.org.
Investigators must submit a Letter of Intent by March 1, 2012 by 11:59 pm ET.
The deadline for receipt of full Grant proposals is April 12, 2012 by 11:59 pm ET.
Full proposals will be accepted only from Investigators whose Letter of Intent was approved.
Targeted Research Initiative for Women with Epilepsy
Application Deadline: March 21, 2012
Award Amount: up to $50,000 maximum for one year Apply via Proposal Central website
The Targeted Research Initiative for Women with Epilepsy grant program was developed to support research that generates initial data leading to more extensive projects that will have direct relevance to care of women with epilepsy. Research should focus on investigation of one of the many areas that preferentially affect women with epilepsy during the reproductive life cycle. The research may target any point along the reproductive spectrum, including puberty through menopause. Examples of topics of interest include, but are not limited to, the following areas: neuroendocrine disorders, hormone influence on seizure susceptibility, infertility, polycystic ovarian syndrome, contraceptive strategies, complications during pregnancy, and pregnancy outcomes.
The Foundation invites research grant applications from interested investigators to conduct innovative research in these areas, ultimately leading to advances in diagnosis and optimal therapeutic strategies for women with epilepsy. The broad focus of this RFP includes both fundamental and clinical research, and encourages translational research. The peer review for this program will assess proposals based not only on scientific merit, but also on relevance to the goals of the program.
Applicants may request up to $50,000 maximum for one year.
Epilepsy Foundation 8301 Professional Place Landover, MD 20785-7223 Telephone: 1-800-332-1000 Fax: 1-301-577-2684 Email: ContactUs@efa.org
Targeted Research Initiative for Severe Symptomatic Epilepsies
Award Amount: up to $50,000 maximum for one year
Apply via Proposal Central website
The Epilepsy Foundation is pleased to announce its first annual Targeted Research Initiative for Severe Symptomatic Epilepsies grant program. This program seeks to better understand, diagnose, identify co morbidities, and treat these rare but devastating epilepsy syndromes. The catastrophic epilepsies of childhood commonly include Othara's syndrome, severe myoclonic epilepsy in infancy (Dravet), infantile spasm, progressive myoclonic epilepsies, Lennox-Gastaut syndrome, Doose syndrome, Sturge-Weber syndrome, Rasmussen encephalitis and, in later childhood, Landau-Kleffner syndrome (LKS) and continuous spike and wave in slow-wave sleep (CSWSS).
Epilepsy Foundation Targeted Research Initiative for Morbidity and Mortality
The Targeted Research Initiative for Morbidity and Mortality supports research that generates initial data leading to more extensive projects that will generate knowledge that will ultimately improve the lives of persons with epilepsy. This initiative recognizes the need for research and new insights into these scientific areas.
The broad focus of the morbidity portion of this program includes: identification of somatic comorbidities in epilepsy that occur more than expected among controls, including but not limited to diabetes, gastrointestinal bleeding, chronic lung disease, congenital cardiac abnormalities, heart failure, and pneumonia; and associations between somatic comorbidities in epilepsy and epilepsy outcomes, including quality of life in epilepsy, seizure remission, stigma and other outcomes.
The mortality portion of the program is focused upon potentially preventable causes of death in epilepsy, such as accidents, suicide and SUDEP. Applicants are encouraged to examine risk factors for these causes of death in epilepsy; as well as interventions to decrease the presence of risk factors for these causes of death where risk factors have been identified.
Targeted Research Initiative for Cognitive and Psychiatric Aspects of Epilepsy
The Targeted Research Initiative for Cognitive and Psychiatric Aspects of Epilepsy supports research leading to new insights into the diagnosis etiology, complications and treatment of persons with epilepsy and mood disorders including comorbid cognitive disorders; depression, anxiety, suicidality, other psychiatric symptoms; and psychogenic non-epileptic seizures.
Call for Applications: American Association of Neuromuscular and Electrodiagnostic Medicine Research Grant
The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) is announcing the availability of a grant opportunity that will be awarded on a competitive basis. The goal of this award is to fund research with high potential to impact patient care through the identification of important relationships between electrodiagnostic measures or imaging modalities with respect to the clinical or functional outcomes of people with neuromuscular disorders. We are seeking high quality, evidence based studies that will provide important information that delineate the role of electrodiagnostic studies in patient management. Studies that assess electrodiagnosis and its relation to outcomes, its ability to promote efficient care and to optimize the use of healthcare resources, as well as complement other diagnostic tests are being solicited. We envision this study to provide class I or II evidence based medicine, demonstrating the impact of electrodiagnosis on patient care and the optimization of resources. Cost effectiveness and care efficiency aspects of proposals are highly desirable.
These disorders include, but are not limited to, common mononeuropathies, cervical and lumbar radiculopathies, peripheral neuropathy, myopathy, neuromuscular junction disorders and motor neuron disorders.
This goal will be accomplished through the peer review grant process with oversight by the AANEM Foundation.
Funds Available and Anticipated Number of Awards The total amount of funding available is $500,000. The foundation anticipates funding 1 project. Projects with direct and indirect costs of up to $100,000 per year will be considered for a 3 to 5 year time span.
Award is contingent upon AANEM Foundation appropriations, and the submission of a meritorious application.
Award Budget Application budgets are limited to $500,000 (direct and indirect costs) and need to reflect actual needs of the proposed project. Overlapping costs will not be allowed. Cost sharing with other funding mechanisms is encouraged. Indirect costs will be capped 7%
Award Project Period The total project period for an application requesting support will be between 3 and 5 years. Funding will not exceed five years.
Eligible Applicants Any physician with the skills, knowledge, and resources necessary to carry out the proposed research as the Principal Investigator (PI) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are particularly encouraged to apply for AANEM foundation support. It is required that either the PI or at least one co-investigator be a member of the AANEM.
Letter of Intent Applicants will be asked to submit a 2 page letter of intent prior to submitting a full proposal. This letter should contain sufficient information to describe the scope of the proposed work, an overview of the scientific rationale and methods to be used, and an indication of the ability of the investigators to complete this work successfully.
From the submitted letters of intent, the Research Committee will select the most promising projects to solicit a full proposal.
Open Date (Earliest Submission Date): Oct. 1, 2012 Letter of Intent Due Date: Dec. 1, 2012 Application Due Date(s): March 31, 2012
AANEM Foundation 2621 Superior Drive NW Rochester, MN 55901 Telephone: 507.288.0100 Fax: 507.288.1225 E-mail: foundation@aanem.org
Travel Fellowships for the 8th Cajal Winter Conference: Neural Plasticity Mechanisms in CNS Diseases
8th Cajal Winter Conference "Neural plasticity mechanisms in CNS diseases"
March 19-23, 2012 Benasque, Huesca (Spain) Travel fellowships
An important task of the Sociedad Española de NeuroCiencia (SENC) is to help young scientists to attend Neuroscience meetings and present their communications. SENC offers travel awards to PhD students and recent postdocs (less than 3 yr after PhD dissertation) to partly cover travel and accommodation expenses. Fellowships of 200 € will be awarded. Applicants should download the CV form from the CWC website and, once filled, upload it before February 15, 2012. Applicants are encouraged to present their communications in oral form.
You will not be able to upload your application if you didn't complete meeting registration previously.
Call for Applications: American Academy for Cerebral Palsy and Developmental Medicine Research Grant Award
Deadline: Monday, April 2, 2012
A key mission of the Academy is to promote excellence in research for the benefit of persons with cerebral palsy and childhood-onset disabilities. One way in which the Academy promotes research is through the annual AACPDM Research Grant.
The AACPDM Research Grant Award provides seed funding to develop a high quality clinical research project/program. The award is expected to produce a competitive interdisciplinary, multi-investigator/center grant proposal for submission to larger agencies/funders of research in any area relevant to the AACPDM. Any member of the AACPDM is eligible to apply. Only one grant application per member will be considered in a given budget year. The budget limit is US $25,000 (subject to approval by the Board, which reserves the right to amend the amount awarded).
Successful applicants are expected to take up the award within one month of the annual AACPDM meeting where the award is announced. The funds must be spent within 18 months. Applicants unable to meet this timeframe will forfeit the grant but will be eligible to re-apply in a subsequent year. Unspent funds after 18 months are expected to be returned to the AACPDM.
Use of Funds The award may be used to fund any of the elements necessary to develop the full grant proposal. These may include costs for:
Teleconferences or meetings of the collaborating team of investigators to plan and develop the research protocol including study design, outcome measures, recruitment strategies, data collection and management, analysis, etc Methodologic/Statistical support or consultation Preparation of application/s for institutional ethics approval Support for investigators time Pilot project/feasibility study in preparation for multi-center project Validation of outcome measures intended for multi-center project
The funds are not intended for:
Institutional indirect costs Purchase of personal computers or equipment Stipends or fees for students or post doctoral fellows
AACPDM Office 555 East Wells, Suite 1100 Milwaukee, WI 53202 Phone: 414.918.3014 Fax: 414.276.2146 Email: info@aacpdm.org URL: www.aacpdm.org Office Hours: 8:00 am - 5:00 pm CST
Cerebral Palsy International Research Foundation Ethel & Jack Hausman Clinical Research Scholars Award
The objective of the Ethel & Jack Hausman Clinical Research Scholars Award is to assist institutions in the United States to recruit promising clinician-investigators early in their careers and to help in their establishment as focal points for scholarly activities in areas of direct relevance to cerebral palsy and related developmental brain disorders; these scholarly activities include research, teaching and associated clinical responsibilities. Candidates for the Award will either be citizens of the United States or have permanent residency status.
The Award is in the amount of $75,000 a year for each of three years. The funds can be used at the discretion of the awardee within the purposes of the Award, the broad confines of the annual approved budget and grantee institutional policy. Supplemental funding from other sources are encouraged. It is expected that Award funds will be used as necessary and appropriate to further the objectives of the Award: the conduct of a clinical research and educational program relevant to cerebral palsy and related developmental brain disorders. A minimal commitment of 60 percent is a requirement of the Award. The clinical research program can be patient based or a combined laboratory–patient endeavor.
Candidates for the Award will have completed their formal clinical and research training and will have recently completed between 4-6 years of post doctoral medical training or 2-4 years of post doctoral research training. However, additional opportunities for formal or informal training appropriate to clinical research is strongly encouraged during the first year of the Award. Support is not available to individuals while in residency or fellowship training. Special explanation of the need for the Award is required of applicants who have completed a research career development award from government or other organizations. It is expected each Awardee will have an appointment in an academic institution and have a sponsor who will serve as a mentor and consultant.
The bar is set high for this award. Applicants must indicate a plan for two or more scientific or clinical publications each of the three years and submission of a subsequent research grant proposal in the second year. Continued funding each year is contingent on meeting these milestones.
The deadline for the receipt of applications is March 1, 2012.
Contact us:
cpirf@cpirf.org 186 Princeton Hightstown Road Building 4, 2nd Floor Princeton Junction, NJ 08550 Phone: 609-452-1200 Fax: 609-452-1201
12next
